Remimazolam (CNS-7056) is a drug which is a benzodiazepine derivative developed as an alternative to the short-acting imidazobenzodiazepine midazolam for use in induction of anaesthesia and conscious sedation for minor invasive procedures.
This page contains content from the copyrighted Wikipedia article "Remimazolam"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.